Stock NYXH NYXOAH SA
Add to a list
To use this feature you must be a member
Log inSign up

All News Nyxoah SA

Equities

NYXH

BE0974358906

Market Closed - Euronext Bruxelles
Other stock markets
 16:37:01 26/04/2024 BST 		5-day change 1st Jan Change
9.6 EUR +2.78% Intraday chart for Nyxoah SA +4.35% +125.35%
04-12 Nyxoah Names New Chief Medical Officer MT
04-12 Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nyxoah Names New Chief Medical Officer
MT
Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer
CI
Nyxoah Appoints Maurits Boon as Chief Medical Officer
MT
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
GL
Top Premarket Decliners
MT
Nyxoah Partners With Medical Association to Lobby Insurers and Regulators
MT
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
GL
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
AQ
Global markets live: Super Micro Computer, Boeing, Vale, Tesla, Nvidia, Intel, Nasdaq...
Our Logo
Stifel Adjusts Nyxoah's Price Target to $27 From $20, Keeps Buy Rating
MT
HC Wainwright Raises Nyxoah Price Target to $22 From $18, Maintains Buy Rating
MT
Nyxoah : Annual Report 2023
PU
Nyxoah Says US Study of Genio System for Sleep Apnea Reaches Primary Endpoints
MT
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
GL
Oppenheimer Adjusts Nyxoah Price Target to $20 From $17, Maintains Outperform Rating
MT
Piper Sandler Raises Nyxoah's Price Target to $20 From $15, Maintains Overweight Rating
MT
Oppenheimer Adjusts Nyxoah Price Target to $17 From $12, Maintains Outperform Rating
MT
Nyxoah S.A. Provides Earnings Guidance for the First Quarter of 2024
CI
Transcript : Nyxoah S.A., Q4 2023 Earnings Call, Mar 05, 2024
Nyxoah S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NYXH Stock
  4. News Nyxoah SA